CCCCNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
C4 Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$2.89+0.13 (+4.52%)
Close on Oct 19, 2026
- Market cap
- $377.71M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of C4 Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Sep 25, 2026 | Sep 25, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 11, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 11, 2026 | Aug 11, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 24, 2026 | Jun 24, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 11, 2026 | Jun 11, 2026 | SEC EDGAR |
| Current report | 8-K | May 15, 2026 | May 15, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 12, 2026 | SEC EDGAR |
| Current report | 8-K | May 12, 2026 | May 12, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 29, 2026 | Apr 29, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 10, 2026 | Apr 10, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 9, 2026 | Apr 9, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Feb 26, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 26, 2026 | Feb 26, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 14, 2026 | Jan 14, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 16, 2025 | Oct 16, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 16, 2025 | Oct 16, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 1, 2025 | Oct 1, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 22, 2025 | Sep 22, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 7, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 18, 2025 | Jun 18, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 7, 2025 | SEC EDGAR |
| Current report | 8-K | May 7, 2025 | May 7, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 29, 2025 | Apr 29, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 14, 2025 | Apr 14, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Feb 27, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 27, 2025 | Feb 27, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 14, 2025 | Jan 14, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 9, 2024 | Dec 9, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 20, 2024 | Nov 20, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Oct 31, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 31, 2024 | Oct 31, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 15, 2024 | Oct 15, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 11, 2024 | Oct 11, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 3, 2024 | Sep 3, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 1, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 1, 2024 | Aug 1, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 21, 2024 | Jun 21, 2024 | SEC EDGAR |